Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
72 Cards in this Set
- Front
- Back
The study of the relationship between a drug's dose, tissue concentration, and elapsed time is called
|
pharmacokinetics (how a body affects a drug).
|
|
The study of drug action, including toxic responses, is called
|
pharmacodynamics (how a drug affects a body).
|
|
The greater the uptake of anesthetic agent, the greater the difference between inspired and alveolar concentrations, and the ....
|
slower the rate of induction.
|
|
Three factors affect anesthetic uptake:
|
solubility in the blood, alveolar blood flow, and the difference in partial pressure between alveolar gas and venous blood.
|
|
Low-output states predispose patients to
|
overdosage with soluble agents, as the rate of rise in alveolar concentrations will be markedly increased.
|
|
7 factors that speed induction also speed recovery:
|
elimination of rebreathing, high fresh gas flows, low anesthetic-circuit volume, low absorption by the anesthetic circuit, decreased solubility, high cerebral blood flow, and increased ventilation.
|
|
General anesthesia is 4 states
|
reversible loss of consciousness,
analgesia of the entire body, amnesia, and some degree of muscle relaxation. |
|
The unitary hypothesis proposes that
|
all inhalation agents share a common mechanism of action at the molecular level. This is supported by the observation that the anesthetic potency of inhalation agents correlates directly with their lipid solubility (Meyer–Overton rule).
|
|
The minimum alveolar concentration (MAC) is
|
is the alveolar concentration of an inhaled anesthetic that prevents movement in 50% of patients in response to a standardized stimulus (eg, surgical incision).
|
|
Prolonged exposure to anesthetic concentrations of nitrous oxide can result in
2X |
bone marrow depression (megaloblastic anemia) and even neurological deficiencies (peripheral neuropathies and pernicious anemia).
|
|
The course of general anesthesia can be divided into three phases:
|
(1) induction, (2) maintenance, and (3) emergence.
|
|
Although the mechanism of action of inhalation anesthetics remains unknown, it is assumed that their ultimate effect depends on attainment of a therapeutic tissue concentration in
|
in the central nervous system
|
|
The actual composition of the inspired gas mixture depends mainly on 3X
|
the fresh gas flow rate, the volume of the breathing system, and any absorption by the machine or breathing circuit
|
|
Tissues can be divided into four groups based on their solubility
|
Vessel Rich
Muscle Fat Vessel Poor The highly perfused vessel-rich group (brain, heart, liver, kidney, and endocrine organs) is the first to take up appreciable amounts of anesthetic. Moderate solubility and small volume limit the capacity of this group, so it is also the first to fill (ie, arterial and tissue partial pressures are equal). The muscle group (skin and muscle) is not as well perfused, so uptake is slower. In addition, it has a greater capacity due to a larger volume, and uptake will be sustained for hours. Perfusion of the fat group nearly equals that of the muscle group, but the tremendous solubility of anesthetic in fat leads to a total capacity (tissue/blood solubility x tissue volume) that would take days to fill. The minimal perfusion of the vessel-poor group (bones, ligaments, teeth, hair, and cartilage) results in insignificant uptake. |
|
The concentration effect is more significant with___________ than with the volatile anesthetics, as the former can be used in much higher concentrations
|
nitrous oxide
|
|
Recovery from anesthesia depends on
|
lowering the concentration of anesthetic in brain tissue
|
|
Anesthetics can be eliminated 3 ways
|
biotransformation, transcutaneous loss, or exhalation
|
|
The most important route for elimination of inhalation anesthetics is
|
alveolus
|
|
diffusion hypoxia is prevented by
|
prevented by administering 100% oxygen for 5–10 min after discontinuing nitrous oxide.
|
|
MAC is a useful measure because it mirrors
|
brain partial pressure, allows comparisons of potency between agents, and provides a standard for experimental evaluations
|
|
The MAC values for different anesthetics are roughly _________.
|
additive
|
|
Roughly 1.3 MAC of any of the volatile anesthetics has been found to prevent movement in
|
95% of patients
|
|
One of the most striking is the ____% decrease in MAC per decade of age, regardless of volatile anesthetic.
|
6%
|
|
only inorganic anesthetic gas in clinical use
|
Nitrous oxide (N2O; laughing gas)
|
|
The circulatory effects of nitrous oxide are explained by
|
its tendency to stimulate the sympathetic nervous system
|
|
Hypoxic drive, the ventilatory response to arterial hypoxia that is mediated by
|
peripheral chemoreceptors in the carotid bodies, is markedly depressed by even small amounts of nitrous oxide.
|
|
nitrous oxide produces a mild elevation of intracranial pressure by...
|
By increasing CBF and cerebral blood volume
|
|
In fact, at high concentrations in hyperbaric chambers, nitrous oxide causes
|
skeletal muscle rigidity
|
|
Nitrous oxide appears to decrease renal blood flow by
|
increasing renal vascular resistance. This leads to a drop in glomerular filtration rate and urinary output.
|
|
Although nitrous oxide is insoluble in comparison with other inhalation agents, it is ____ times more soluble than nitrogen in blood.
|
35
|
|
Examples of conditions in which nitrous oxide might be hazardous include
|
air embolism,
pneumothorax, acute intestinal obstruction, intracranial air (tension pneumocephalus following dural closure or pneumoencephalography), pulmonary air cysts, intraocular air bubbles, and tympanic membrane grafting. |
|
Because of the effect of nitrous oxide on the pulmonary vasculature, it should be avoided in patients with
|
pulmonary hypertension.
|
|
Halothane is a
|
halogenated alkane
|
|
Halothane
Cardiovascular |
Cardiac depression—from interference with sodium–calcium exchange and intracellular calcium utilization
|
|
It is prudent to withhold halothane from patients 3X
|
unexplained liver dysfunction
intracranial mass lesions because of the possibility of intracranial hypertension Hypovolemic patients and some patients with severe cardiac disease |
|
Isoflurane
Cardiovascular |
Isoflurane causes minimal cardiac depression
|
|
Cerebral
Isoflurane |
At concentrations greater than 1 MAC, isoflurane increases CBF and intracranial pressure
At concentrations greater than 1 MAC, isoflurane increases CBF and intracranial pressure |
|
Isoflurane is metabolized to
|
trifluoroacetic acid
|
|
Isoflurane
Contraindications |
Isoflurane presents no unique contraindications. Patients with severe hypovolemia may not tolerate its vasodilating effects.
|
|
The structure of desflurane is very similar to that of isoflurane. In fact, the only difference is
|
is the substitution of a fluorine atom for isoflurane's chlorine atom.
|
|
Desflurane
blood/gas partition coefficient |
(0.42)
|
|
Although desflurane is roughly ________ as potent as the other volatile agents, it is 17 times more potent than nitrous oxide.
|
one-fourth
|
|
MH Episodes
Treatment involves |
notifying the surgeon, discontinuing volatile agents or SCh,
giving 100% O2, stopping anesthesia or continuing with nontriggers, dantrolene 2.5 mg/kg, hyperventilation for respiratory acidosis, bicarbonate for metabolic acidosis, cooling for high temperatures, diuresis for pigmenturia, and calcium if there is dangerous hyperkalemia. |
|
how a body effects a drug
|
-Pharmokinetics-
|
|
how a drug affects a body
|
Pharmacodynamics-
|
|
4 Factors affecting inspiratory concentration
|
fresh gas flow rate, volume of the breathing system, absorption by the machine or breathing circuit.
|
|
Factors effecting alveolar concentration-
|
The greater the uptake, the slower the rate of rise of alveolar concentration and the lower the FA:FI ratio. Avleolar partial pressure is important bc it determines the partial pressure of anesthetic in the blood and ultimately the brain. The greater the uptake of anesthetic agent, the greater the difference between inspired and alveolar concentrations, and the slower the rate of induction.
|
|
3 factors that affect anesthetic uptake
|
- solubility in the blood, alveolar blood flow, and the difference in partial pressure between alveolar gas and venous blood.
|
|
Equilibrium is defined as
|
equal partial pressure in two phases. For example, the blood/gas partition coefficient of N20 at 37 degress celsius is 0.47. At equilibrium, 1 ml of blood contains 0.47 as much N20 as does 1ml of alveolar gas even though partial pressures are same.
|
|
Low output states predisposes patients to
|
overdosage with soluble agents.
|
|
The transfer of anesthetic from blood to tissue is determined by three factors:
|
tissue solubility of the agent, tissue blood flow, and the difference in partial pressure between arterial blood and tissue.
|
|
-Tissues can be divided into 4 groups based on their solubility and blood flow:
|
1. Highly perfused vessel rich group ( brain, heart, liver, kidney, and endocrine organ.) this group is first to fill.
2. muscle group (skin and muscle)-not as well perfused, so uptake slower. Larger volume as well. 3. fat 4. vessel poor group which is minmial perfusion (ie bones, ligaments, teeth, hair, cartilage). |
|
Second gas effect-
|
a high concentration of N20 will augment not only its own uptake but theoretically that of a concurrent administered volatile anesthetic. M and M states second gas effect is probably insignificant.
|
|
3 Factors effecting elimination
|
biotransformation, transcutaneous loss, or exhalation.
|
|
7 -Factors that speed recovery
|
elimination of rebreathing,
high fresh gas flows, low anesthetic-circuit volume, low absorption by the anesthetic circuit, decreased solubilty, high cerebral blood flow, and increased ventilation |
|
Diffusion hypoxia-
|
Elimination of N20 is so rapid that alveolar O2 and Co2 are diluted. You can prevent it by giving 100% O2 for 5-10 min after discontinuing N20.
|
|
-The MAC
|
(minimum alveolar concentration) of an inhaled agent is the alveolar concentration that prevents 50% of patients to move with a standard stimulus. MAC mirrors brain partial pressure, which makes it a good tool. 1.3 MAC reduces movement with 95% of patients.
|
|
-MAC decreases____ per decade of age, regardless what volatile anesthetic is used.
|
6%
|
|
N20 tends to stimulate
|
sympathetic nervous system. Because N2) increases endogenous catecholamine levels, it may be associated with higher incidence of epinephrine induced arrhythmias
|
|
Do not give N20 to
__________ due to tetragenic effects |
pregnant people
|
|
-N20 decreases MAC by aprox. _____%
|
50%
|
|
Do not give these 6 patients N20
|
air embolism,
pneumothorax, acute intestinal obstruction, intracranial air (tension pneuocephalus following closure or pneumoenephalography, pulmonary air cysts, intraocular air bubbles, tympanic membrane grafting. |
|
halothane sesnitizes the heart to
|
to the arrhythmogenic effects of epinephrine, so that doses of epinephrine above 1.5 mcg/kg should be avoided.
|
|
Apnic threshold
|
PACO2 at which a patient remains apnic.
|
|
Halothane Hepatitis
|
is extremely rare (1 in 35,000 cases). Risks include multiplie exposures, middle aged obese women, familial predisposition to halothane toxicity. Hold halothane with anyone that has unexplained liver dysfunction
|
|
Isolurane- FYI
|
Cardiac output is maintained by a rise in hear rate due to partial preservation of carotid baroflexes. Conflicting reports on coronary steal sydnrome. (which may cause myocardial ischemia during episodes of tachycardia or drops in perfusion pressure. Some Anesthesia providers avoid iso with patients that have CAD due to this theory.
-At 2 MAC Iso produces an electrically silent EEG. |
|
Desflurane- FYI
|
-low solubility of desflurane causes a rapid wash in and washout of the drug. Wake-up time is 50% less longer than ISO wake-up time. Desflurane is roughly ¼ as potent as the other volatile agents, it is 17 times more potent than N20. High vapor pressure (681 mm hg) and short duration, moderate potency are all characteristics of Des.
-Rapid increase in desflurane can cause elevated catecholamines and increased HR. Unlike Isoflurane, Desflurane does not increase coraonary artery blood flow. -Desflurand (more than other agents) can be degraded by desiccated CO2 absorbent into potentially significant levels of carbon monoxide. -Desflurane emergence is associated with delerium in some pediatric patients |
|
Rapid increase in desflurane can cause
|
elevated catecholamines and increased HR
|
|
Desflurand (more than other agents) can be degraded by desiccated CO2 absorbent into potentially significant levels
|
levels of carbon monoxide.
|
|
Sevoflurane FYI
|
- nonpungent, good for inhalational induction. Also can be associated with delerium with pediatric patients.
-Sevo may prolong QT interval -Sevo is not associated with increased HR (like des and iso) -Barium hydroxide can degrade SEVO, producing nephrotoxic compound A (proven in rat studies) keep fresh gas flow a 2l, and do not administer to patients with kidney insufficiency. |
|
anatomic dead space=
|
1ml/kg. Which is aprox 70 ml pre breath for normal person
|
|
Equipment dead space=
|
Compliance X pressure
= approx 200ml/breath |